Therapy News and Research

RSS

Survey says half of people with rheumatoid disease struggle to pay for treatment

Rheumatoid disease encompasses inflammatory conditions that affect the joints, muscle, bones, and organs. A new study found that despite 90 of patients have health insurance, nearly 60 percent said that they are struggling to afford medication or treatment in the last year.

16 Sep 2019

New biomarkers help predict response to treatment in common brain tumor

Many scientists have noted that there is a link between inflammation or the immune response, and patient survival. One such possible relationship is the association of blood markers and the prognosis in the brain tumor called medulloblastoma.

16 Sep 2019

Uncovering new T cell regulatory processes could help treat autoimmune disease

One of the important cells involved in the immune response is the T follicular helper (Tfh) cell. These are important in the normal process of antibody production following immunization, for instance. However, they are also abnormally increased in number in patients with autoimmune disease, such as systemic lupus erythematosus.

16 Sep 2019

Higher hospital-wide use of antibiotics linked to more C. difficile infections

Higher hospital-wide use of four classes of antibiotics thought to increase the risk of the dangerous intestinal illness.

16 Sep 2019

New platform uses nanoparticles to deliver anti-cancer agent to cells

Scientists from the University of Cambridge have developed a platform that uses nanoparticles known as metal-organic frameworks to deliver a promising anti-cancer agent to cells.

16 Sep 2019

Acute therapy with vitamin E may offer effective low-cost treatment for heart attack

Heart attack is a leading cause of death worldwide and new treatment strategies are highly sought-after. Unfortunately lasting damage to the heart muscle is not uncommon following such an event.

16 Sep 2019

Developing a highly predictive genetic risk score for type 1 diabetes

Paul Tran is working to develop a highly predictive genetic risk score that will tell parents whether their baby is at significant risk for type 1 diabetes.

16 Sep 2019

Drugs used to treat retinal diseases are excreted into human breast milk, study finds

Certain drugs used to treat retinal diseases are excreted into breast milk, raising possible safety concerns for developing infants, suggests a first-of-its-kind study led by St. Michael's Hospital in Toronto and published in Ophthalmology.

15 Sep 2019

Children's Tumor Foundation harnesses interest in rare disease research through NF Innovation Week

Neurofibromatosis, a genetic disorder that causes tumors to grow on nerves throughout the body and which affects 1 in 3,000 people - that's over 2.5 million worldwide - has no cure and few workable treatment options.

15 Sep 2019

Nano-sized bubbles in our body could effectively fight cancer

Healthy cells in our body release nano-sized bubbles that transfer genetic material such as DNA and RNA to other cells. It's your DNA that stores the important information necessary for RNA to produce proteins and make sure they act accordingly.

15 Sep 2019

Editing away cancer and HIV in China: win or lose?

Scientists in China recently edited out the CCR5 gene from a patient with HIV's stem cells, but the research has sparked ethical debate.

13 Sep 2019

CRISPR may explain why so many experimental cancer drugs fail

Scientists have used CRISPR–Cas9 to investigate how ten cancer drugs interact with their protein target, revealing some intriguing findings.

13 Sep 2019

Distinctive characteristics in lung cancers could be key to personalized therapies

Melbourne researchers have discovered that the key to personalized therapies for some types of lung cancers may be to focus on their differences, not their similarities.

13 Sep 2019

B cells may play an important role in immunotherapy for melanoma

Researchers at EMBL's European Bioinformatics Institute and the Medical University of Vienna have found evidence that B cells might play an important role in immunotherapy for melanoma.

13 Sep 2019

Parkinson’s patients benefit from “gamified” home exercise

Exercise is always difficult to sustain for more than a short period, in most cases. This is all the more true if you’re already sick or in pain, or find movements difficult, as with Parkinson’s disease.

13 Sep 2019

Abnormal gut bacteria linked to poor cognitive performance in vets with PTSD and cirrhosis

A study involving military veterans with PTSD and cirrhosis of the liver points to an abnormal mix of bacteria in the intestines as a possible driver of poor cognitive performance--and as a potential target for therapy.

13 Sep 2019

Texas Biomed researchers pinpoint important mechanism behind TB/HIV co-infection

Tuberculosis and HIV - two of the world's deadliest infectious diseases - are far worse when they occur together. Now, Texas Biomedical Research Institute researchers have pinpointed an important mechanism at work in this troubling health problem.

13 Sep 2019

Promising new drug being developed for polycystic kidney disease

Researchers have developed a potential new drug for the treatment of Polycystic kidney disease (PKD) – a deadly genetic condition affecting the kidneys that leads to formation of swellings or cysts within the kidney that cause it to fail.

12 Sep 2019

New gene therapy helps stroke patients develop new neurons

Ischemic stroke is a condition in which parts of the brain lose their blood supply, causing nerve damage. Once brain tissue suffers irreparable harm, the patient will experience irreversible disability or death, depending on the extent of neuronal loss.

12 Sep 2019

Metastatic colorectal cancer patients with certain BRAF mutations may respond to anti-EGFR therapy

Patients with metastatic colorectal cancer harboring a subset of non-V600 mutations in the BRAF gene, known as class 3 BRAF mutations, were more likely to respond to anti-EGFR treatment.

12 Sep 2019

Therapy News and Research

Survey says half of people with rheumatoid disease struggle to pay for treatment

New biomarkers help predict response to treatment in common brain tumor

Uncovering new T cell regulatory processes could help treat autoimmune disease

Higher hospital-wide use of antibiotics linked to more C. difficile infections

New platform uses nanoparticles to deliver anti-cancer agent to cells

Acute therapy with vitamin E may offer effective low-cost treatment for heart attack

Developing a highly predictive genetic risk score for type 1 diabetes

Drugs used to treat retinal diseases are excreted into human breast milk, study finds

Children's Tumor Foundation harnesses interest in rare disease research through NF Innovation Week

Nano-sized bubbles in our body could effectively fight cancer

Editing away cancer and HIV in China: win or lose?

CRISPR may explain why so many experimental cancer drugs fail

Distinctive characteristics in lung cancers could be key to personalized therapies

B cells may play an important role in immunotherapy for melanoma

Parkinson’s patients benefit from “gamified” home exercise

Abnormal gut bacteria linked to poor cognitive performance in vets with PTSD and cirrhosis

Texas Biomed researchers pinpoint important mechanism behind TB/HIV co-infection

Promising new drug being developed for polycystic kidney disease

New gene therapy helps stroke patients develop new neurons

Metastatic colorectal cancer patients with certain BRAF mutations may respond to anti-EGFR therapy

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News